PLAY PODCASTS
Moderna Cuts Vaccine Outlook, Qualcomm Shares Surge, Kyndryl Begins Trading

Moderna Cuts Vaccine Outlook, Qualcomm Shares Surge, Kyndryl Begins Trading

Carl Quintanilla, Jim Cramer and David Faber began the show with a look at Moderna shares sliding, after cutting its Covid-19 vaccine sales forecast. The company is now expecting to deliver between 700-800 million does this year, down from previous expectations of between 800 million and 1 billion doses. The anchors also interviewed Qualcomm CEO, Cristiano Amon, a day after the company reported a strong earnings beat. Qualcomm’s chip sales for smartphones were up 56% year over year. Also in the mix: IBM spinoff Kyndryl began trading at the NYSE under ticker “KD.” CEO Martin Schroeter joined the crew ahead of the newly public company’s first trade.

Squawk on the Street

November 4, 202146m 12s

Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Original episode page

Show Notes

Carl Quintanilla, Jim Cramer and David Faber began the show with a look at Moderna shares sliding, after cutting its Covid-19 vaccine sales forecast. The company is now expecting to deliver between 700-800 million does this year, down from previous expectations of between 800 million and 1 billion doses. The anchors also interviewed Qualcomm CEO, Cristiano Amon, a day after the company reported a strong earnings beat. Qualcomm’s chip sales for smartphones were up 56% year over year. Also in the mix: IBM spinoff Kyndryl began trading at the NYSE under ticker “KD.” CEO Martin Schroeter joined the crew ahead of the newly public company’s first trade. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.
← All episodes of Squawk on the Street